| Lung Neuroendocrine Tumor studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665739Phase 2 · recruiting Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors · condition mapped CURATED_BROADER · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03879694Phase 1 · completed Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915144Phase 2 · withdrawn 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03707925NA · terminated Bronchoscopic Laser Ablation of Peripheral Lung Tumors · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085081NA · withdrawn Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03923777NA · unknown Active Surveillance in Early Lung Cancer · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093782Phase 2 · completed Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548482Phase 1 · completed Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084461Phase 2 · terminated Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 17 trials mapped (4 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |